Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trial

Autor: M. S. Walma, S. J. Rombouts, L. J. H. Brada, I. H. Borel Rinkes, K. Bosscha, R. C. Bruijnen, O. R. Busch, G. J. Creemers, F. Daams, R. M. van Dam, O. M. van Delden, S. Festen, P. Ghorbani, D. J. de Groot, J. W. B. de Groot, N. Haj Mohammad, R. van Hillegersberg, I. H. de Hingh, M. D’Hondt, E. D. Kerver, M. S. van Leeuwen, M. S. Liem, K. P. van Lienden, M. Los, V. E. de Meijer, M. R. Meijerink, L. J. Mekenkamp, C. Y. Nio, I. Oulad Abdennabi, E. Pando, G. A. Patijn, M. B. Polée, J. F. Pruijt, G. Roeyen, J. A. Ropela, M. W. J. Stommel, J. de Vos-Geelen, J. J. de Vries, E. M. van der Waal, F. J. Wessels, J. W. Wilmink, H. C. van Santvoort, M. G. Besselink, I. Q. Molenaar, for the Dutch Pancreatic Cancer Group

Publikováno v: Trials, Vol 22, Iss 1, Pp 1-12 (2021)

Abstract Background Approximately 80% of patients with locally advanced pancreatic cancer (LAPC) are treated with chemotherapy, of whom approximately 10% undergo a resection. Cohort studies investigating local tumor ablation with radiofrequency ablat

Externí odkaz: https://doaj.org/article/3d301f6bd2bd4bac89f7f45ee7d3f040

Additional file 6 of Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trial

Autor: M. S. Walma, S. J. Rombouts, L. J. H. Brada, I. H. Borel Rinkes, K. Bosscha, R. C. Bruijnen, O. R. Busch, G. J. Creemers, F. Daams, R. M. Van Dam, O. M. Van Delden, S. Festen, P. Ghorbani, D. J. De Groot, J. W. B. De Groot, N. Haj Mohammad, R. Van Hillegersberg, I. H. De Hingh, M. D’Hondt, E. D. Kerver, M. S. Van Leeuwen, M. S. Liem, K. P. Van Lienden, M. Los, V. E. De Meijer, M. R. Meijerink, L. J. Mekenkamp, C. Y. Nio, I. Oulad Abdennabi, E. Pando, G. A. Patijn, M. B. Polée, J. F. Pruijt, G. Roeyen, J. A. Ropela, M. W. J. Stommel, J. De Vos-Geelen, J. J. De Vries, E. M. Van Der Waal, F. J. Wessels, J. W. Wilmink, H. C. Van Santvoort, M. G. Besselink, I. Q. Molenaar

Additional file 6. Translation METC document.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12403bd3f019fab416ca102e77096df7

Additional file 4 of Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trial

Autor: M. S. Walma, S. J. Rombouts, L. J. H. Brada, I. H. Borel Rinkes, K. Bosscha, R. C. Bruijnen, O. R. Busch, G. J. Creemers, F. Daams, R. M. Van Dam, O. M. Van Delden, S. Festen, P. Ghorbani, D. J. De Groot, J. W. B. De Groot, N. Haj Mohammad, R. Van Hillegersberg, I. H. De Hingh, M. D’Hondt, E. D. Kerver, M. S. Van Leeuwen, M. S. Liem, K. P. Van Lienden, M. Los, V. E. De Meijer, M. R. Meijerink, L. J. Mekenkamp, C. Y. Nio, I. Oulad Abdennabi, E. Pando, G. A. Patijn, M. B. Polée, J. F. Pruijt, G. Roeyen, J. A. Ropela, M. W. J. Stommel, J. De Vos-Geelen, J. J. De Vries, E. M. Van Der Waal, F. J. Wessels, J. W. Wilmink, H. C. Van Santvoort, M. G. Besselink, I. Q. Molenaar

Additional file 4. SPIRIT checklist.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::165f55a21644e7abea41c1a53588fbe7

Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trial

Autor: Mathieu D'Hondt, Sebastiaan Festen, Rutger C G Bruijnen, O.M. van Delden, E. M. van der Waal, I.H.J.T. de Hingh, J. A. Ropela, J. de Vos-Geelen, Johanna W. Wilmink, Chung Y. Nio, R.M. van Dam, Derk Jan A. de Groot, Geert Roeyen, J.W.B. de Groot, K.P. van Lienden, N. Haj Mohammad, S. J. Rombouts, O.R.C. Busch, Lilly J H Brada, G.J.M. Creemers, M. Liem, Gijs A. Patijn, J. de Vries, F. Daams, I.Q. Molenaar, V. E. de Meijer, M. S. van Leeuwen, Maartje Los, Leonie J. M. Mekenkamp, M.S. Walma, I. Oulad Abdennabi, P. Ghorbani, Martijn W J Stommel, H.C. van Santvoort, Elizabeth Pando, Emile D. Kerver, I. H. M. Borel Rinkes, J.F.M. Pruijt, R. van Hillegersberg, Koop Bosscha, Frank J. Wessels, Martijn R. Meijerink, Marc G. Besselink, Marco B. Polee

Publikováno v: Trials, 22, 1
Trials
Trials, 22
Trials, 22(1):313. BioMed Central
Dutch Pancreatic Cancer Group 2021, ' Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trial ', Trials, vol. 22, no. 1, 313 . https://doi.org/10.1186/s13063-021-05248-y
Trials, 22(1):313. BioMed Central Ltd
TRIALS, 22(1):313, 1-12. BMC
Scientia
Trials, Vol 22, Iss 1, Pp 1-12 (2021)

Background Approximately 80% of patients with locally advanced pancreatic cancer (LAPC) are treated with chemotherapy, of whom approximately 10% undergo a resection. Cohort studies investigating local tumor ablation with radiofrequency ablation (RFA)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3471da294f3f1dbd689adeaf8e6be22
https://repository.ubn.ru.nl/handle/2066/239066

Systematic review of the surgical strategies of adenocarcinomas of the gastroesophageal junction

Autor: R. van Hillegersberg, Peter D. Siersema, M. S. van Leeuwen, Leonie Haverkamp, Jelle P. Ruurda

Publikováno v: Surgical Oncology. 23:222-228

Introduction The optimal surgical treatment of patients with adenocarcinoma of the gastroesophageal junction has not been established yet. Objective To evaluate the surgical strategies to treat adenocarcinoma of the gastroesophageal junction. Methods

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e36a8f369d70ca906e7c05455717c5e
https://doi.org/10.1016/j.suronc.2014.10.004